Abnormal behaviours during pramipexole treatment for Cotard's syndrome: a case report

被引:2
作者
Maruo, Joji [1 ]
Haraguchi, Yoshinori [1 ]
Tateishi, Hiroshi [1 ]
Noguchi, Tomoyuki [1 ]
Mizoguchi, Yoshito [1 ]
Kato, Takahiro A. [1 ]
Kawashima, Toshiro [1 ]
Monji, Akira [1 ]
机构
[1] Saga Univ Hosp, Dept Psychiat, 5-1-1 Nabeshima, Saga 8498501, Japan
关键词
augmentation; compulsive behaviours; depressive disorders; Lewy body disease; pramipexole; DOPAMINE AGONIST; DEPRESSION; AUGMENTATION; LIFE;
D O I
10.1111/psyg.12148
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Cotard's syndrome is a relatively rare condition that involves a delusion of negation in which an individual believes he or she has lost his or her soul, is dead, or is without functional body systems. This syndrome is observed in various neuropsychiatric disorders but most commonly in mood disorders. Pramipexole has often been used in the adjunctive treatment of both bipolar and unipolar depression, and it is known to cause rare but serious adverse effects such as compulsive behaviours in the treatment of Parkinson's disease. Here we report a case of Cotard's syndrome in treatment-resistant major depression associated with abnormal behaviours that might be caused by pramipexole. In the present case, the patient's abnormal behaviours gradually disappeared about 2 months after the discontinuation of pramipexole. The hypoperfusion in the bilateral parieto-occipital lobe found on single-photon emission computed tomography suggests the presence of Lewy body disease pathology. Nonetheless, the patient's abnormal behaviours disappeared after the discontinuation of pramipexole, indicating that they are mainly attributable to pramipexole treatment. However, the possible existence of Lewy body pathology could facilitate the emergence of abnormal behaviours after treatment with pramipexole. The patient's abnormal behaviours, such as eating other patients' food and taking her medicine before the scheduled time, might differ from typical compulsive behaviours induced by pramipexole (such as pathological gambling and hypersexuality), but they could be regarded as disinhibition. Therefore, we should follow up on the clinical course of this case carefully through neuroimaging investigation and neurocognitive assessment.
引用
收藏
页码:283 / 286
页数:4
相关论文
共 16 条
  • [1] Pramipexole in psychiatry: A systematic review of the literature
    Aiken, Chris B.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (08) : 1230 - 1236
  • [2] A possible substrate for dopamine-related changes in mood and behavior: Prefrontal and limbic effects of a D3-preferring dopamine agonist
    Black, KJ
    Hershey, T
    Koller, JM
    Videen, TO
    Mintun, MA
    Price, JL
    Perlmutter, JS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (26) : 17113 - 17118
  • [3] Pramipexole Reduces Phosphorylation of α-Synuclein at Serine-129
    Chau, Kai-Yin
    Cooper, J. Mark
    Schapira, Anthony Henry V.
    [J]. JOURNAL OF MOLECULAR NEUROSCIENCE, 2013, 51 (02) : 573 - 580
  • [4] A Randomized, Double-Blind, Placebo-Controlled Trial of Pramipexole Augmentation in Treatment-Resistant Major Depressive Disorder
    Cusin, Cristina
    Iovieno, Nadia
    Iosifescu, Dan V.
    Nierenberg, Andrew A.
    Fava, Maurizio
    Rush, A. John
    Perlis, Roy H.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2013, 74 (07) : E636 - E641
  • [5] Dopamine agonist-responsive depression
    Hori, Hiroaki
    Kunugi, Hiroshi
    [J]. PSYCHOGERIATRICS, 2013, 13 (03) : 189 - 195
  • [6] The Efficacy of Pramipexole, a Dopamine Receptor Agonist, as an Adjunctive Treatment in Treatment-Resistant Depression: An Open-Label Trial
    Hori, Hiroaki
    Kunugi, Hiroshi
    [J]. SCIENTIFIC WORLD JOURNAL, 2012,
  • [7] Pramipexole for stage 2 treatment-resistant major depression: An open study
    Inoue, Takeshi
    Kitaichi, Yuji
    Masui, Takuya
    Nakagawa, Shin
    Boku, Shuken
    Tanaka, Teruaki
    Suzuki, Katsuji
    Nakato, Yasuya
    Usui, Reiko
    Koyama, Tsukasa
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (08) : 1446 - 1449
  • [8] Kolla BP, 2010, PSYCHOSOMATICS, V51, P271, DOI 10.1176/appi.psy.51.3.271
  • [9] Bromocriptine augmentation therapy in a patient with Cotard's syndrome
    Kondo, S
    Hayashi, H
    Eguchi, T
    Oyama, T
    Wada, T
    Otani, K
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2003, 27 (04) : 719 - 721
  • [10] PRAMIPEXOLE BINDING AND ACTIVATION OF CLONED AND EXPRESSED DOPAMINE D-2, D-3 AND D-4 RECEPTORS
    MIERAU, J
    SCHNEIDER, FJ
    ENSINGER, HA
    CHIO, CL
    LAJINESS, ME
    HUFF, RM
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1995, 290 (01): : 29 - 36